MedPath

Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

Not yet recruiting
Conditions
Bleomycin Adverse Reaction
Registration Number
NCT06510829
Lead Sponsor
Assiut University
Brief Summary

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :

* Clinically based on Change in the Size and Color of Hemangioma.

* Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology .

* Comparison of Complications associated with Bleomycin and Diode Laser.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age between 3 Months and 1 Year old.
  • Non Complicated Infantile Hemangioma
Exclusion Criteria
  • Younger than 3 Months or older than 1 Year.
  • Complicated Infantile Hemangioma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of diode laser on hemangioma3 years
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.